Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19-month-old male with severe hemophilia A

Pediatr Blood Cancer. 2024 Aug;71(8):e31081. doi: 10.1002/pbc.31081. Epub 2024 May 16.

Authors

Jessica N Mistretta¹, Maria G Español^{1

2}, Michael D Tarantino^{1

2}, Dane C Christ¹, Maureen D Jones¹, Jonathan C Roberts^{1

2}

Affiliations

¹ Bleeding & Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI, Peoria, Illinois, USA.
² Departments of Pediatrics and Medicine, University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA.

PMID: 38753403
DOI: 10.1002/pbc.31081

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Factor VIII / therapeutic use
Hemophilia A* / complications
Hemophilia A* / drug therapy
Humans
Infant
Male

Substances

Factor VIII